| |
| |
|
| Insider
Information: |
Milligan Sandra |
| Relationship: |
Director |
| City: |
Jersey City |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,599 |
|
|
Indirect Shares
|
32,000 |
|
|
| Direct
Value |
$538,519 |
|
|
|
Indirect Value
|
$22,640 |
|
|
| Total
Shares |
60,599 |
|
|
| Total
Value |
$561,159 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Organon & Co. |
OGN |
Head of Research & Dev... |
2023-05-04 |
28,599 |
2022-02-28 |
0 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
Director |
2023-11-15 |
0 |
2023-11-15 |
32,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GOSS |
Gossamer Bio Inc |
Director |
– • – |
2023-11-15 |
4 |
B |
$0.79 |
$25,213 |
I/I |
32,000 |
32,000 |
2.1 |
% |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-05-04 |
4 |
D |
$24.24 |
$52,552 |
D/D |
(2,168) |
28,599 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,984 |
30,767 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-05-01 |
4 |
D |
$24.63 |
$20,344 |
D/D |
(826) |
25,783 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,899 |
26,609 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-02-28 |
4 |
D |
$25.09 |
$58,861 |
D/D |
(2,346) |
20,861 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,976 |
23,207 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-04 |
4 |
D |
$32.44 |
$58,587 |
D/D |
(1,806) |
15,231 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,984 |
17,037 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-03 |
4 |
D |
$32.08 |
$16,842 |
D/D |
(525) |
12,053 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,842 |
12,578 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-01 |
4 |
D |
$32.33 |
$17,458 |
D/D |
(540) |
10,736 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,896 |
11,276 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-02-28 |
4 |
D |
$37.57 |
$110,493 |
D/D |
(2,941) |
9,380 |
0 |
- |
|
| OGN |
Organon & Co. |
Head of Research & Development |
• – – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,171 |
12,321 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
